drugset / Trial / NCT01656603

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

NCT01656603 ↗

Phase 2 Recruiting 9999 enrolled New York Blood Center
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.

Timeline

Start
2012-02
Primary completion
2030-12
Completion
2030-12

Drugs

EvaluationDrugModalityDoseRoute
Subject unlicensed CBU Cell therapy — Other

Indications

No indication recorded.